Low Dose Naltrexone (LDN) & Autoimmune Conditions

Managing Autoimmune Conditions with Low Dose Naltrexone

Low Dose Naltrexone (LDN) was first used for autoimmune conditions. In fact, one of the first LDN studies was done on patients with Crohn’s Disease. LDN has unique immune modulating properties which help calm the immune system and can help improve autoimmune disease symptoms.

Current treatments for autoimmune disease include expensive medications that suppress a certain part of your immune system. While this may help with some of your symptoms, you are more vulnerable to developing other infections.

Low dose naltrexone (LDN) can be a good, low cost and low risk option for your autoimmune condition and can also be used together with other medications. Below is a sampling of studies on LDN and its use in a variety of autoimmune conditions.

If you are interested in learning more about LDN for chronic pain, check out one of our webinars (link to webinars) or Contact Us to learn more.

If you would like to get started with LDN, talk to your health care provider or complete our LDN History Form and we will work with your provider to get you started.

To learn more about this viable option for autoimmune conditions, feel free to download and read these publicly available, scholarly articles.

Low Dose Naltrexone in Multiple Sclerosis: Effects on Medication Use. A Quasi-Experimental Study

Long-Term Treatment with Low-Dose Naltrexone Maintains Stable Health in Patients with Multiple Sclerosis

Serum [Met]-enkephalin Levels are Reduced in Multiple Sclerosis and Restored by Low-Dose Naltrexone

Therapy with the Opioid Antagonist Naltrexone Promotes Mucosal Healing in Active Crohn’s Disease: A Randomized Placebo-Controlled Trial

See additional resources below. If you would like to receive articles like these monthly, subscribe to our newsletter by clicking here.

Low Dose Naltrexone has been the subject of much debate but actually very few large clinical trials. The reason for this is the lack of funding for these large clinical trials. Most of the trials are small but were conducted by physicians using LDN in......